Evaluating the effect of ketamine and remifentanil combination with ketamine and propofol on pain and agitatio
Phase 3
Completed
- Conditions
- Postoperative Pain.
- Registration Number
- IRCT20181127041768N1
- Lead Sponsor
- Sanandaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
ASA status equal to 1
The patient undergoes nose bone closed fracture reduction
Age from 18 to 60 years old.
Exclusion Criteria
History of Hypertension
Hyperthyroidism
Mental disorders
History of coronary artery disease
Drug use
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie ketamine's analgesic effects in postoperative pain management?
How does the combination of ketamine and remifentanil compare to ketamine and propofol in managing postoperative pain and agitation in nasal bone reduction procedures?
Are there specific biomarkers that can predict patient response to ketamine-based combinations in postoperative settings?
What are the potential adverse events associated with ketamine-remifentanil versus ketamine-propofol regimens in clinical practice?
How do ketamine and remifentanil combinations influence hemodynamic stability compared to other anesthetic agents in nasal surgery?